VWR (VWR) Announces Acquisition of BioArra and Reliable Biopharmaceutical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall St opens lower as Meta Platforms, economic data weigh
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil steady as US demand concerns balance Middle East conflict risks
- Dollar firmer on higher U.S. inflation; yen sinks vs euro, US currency
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- Meta Platforms, IBM, Caterpillar fall premarket; American Airlines, Chipotle rise
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
VWR (VWR) Tops Q3 EPS by 1c
November 3, 2016 8:59 AM EDTVWR (NASDAQ: VWR) reported Q3 EPS of $0.44, $0.01 better than the analyst estimate of $0.43. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.15 billion.VWR reaffirmed FY2016 guidance.
Acquisition:
VWR also announced the acquisition of two companies, Reliable Biopharmaceutical and BioArra, earlier today.
... More
